Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 129

1.

A common nonsynonymous single nucleotide polymorphism in the SLC30A8 gene determines ZnT8 autoantibody specificity in type 1 diabetes.

Wenzlau JM, Liu Y, Yu L, Moua O, Fowler KT, Rangasamy S, Walters J, Eisenbarth GS, Davidson HW, Hutton JC.

Diabetes. 2008 Oct;57(10):2693-7. doi: 10.2337/db08-0522. Epub 2008 Jun 30.

2.

Autoantibodies to zinc transporter 8 and SLC30A8 genotype stratify type 1 diabetes risk.

Achenbach P, Lampasona V, Landherr U, Koczwara K, Krause S, Grallert H, Winkler C, Pflüger M, Illig T, Bonifacio E, Ziegler AG.

Diabetologia. 2009 Sep;52(9):1881-8. doi: 10.1007/s00125-009-1438-0. Epub 2009 Jul 10.

PMID:
19590848
3.

Association between anti-ZnT8 autoantibody specificities and SLC30A8 Arg325Trp variant in Japanese patients with type 1 diabetes.

Kawasaki E, Uga M, Nakamura K, Kuriya G, Satoh T, Fujishima K, Ozaki M, Abiru N, Yamasaki H, Wenzlau JM, Davidson HW, Hutton JC, Eguchi K.

Diabetologia. 2008 Dec;51(12):2299-302. doi: 10.1007/s00125-008-1165-y. Epub 2008 Oct 11.

PMID:
18850084
4.

Zinc transporter 8 autoantibodies and their association with SLC30A8 and HLA-DQ genes differ between immigrant and Swedish patients with newly diagnosed type 1 diabetes in the Better Diabetes Diagnosis study.

Delli AJ, Vaziri-Sani F, Lindblad B, Elding-Larsson H, Carlsson A, Forsander G, Ivarsson SA, Ludvigsson J, Kockum I, Marcus C, Samuelsson U, Örtqvist E, Groop L, Bondinas GP, Papadopoulos GK, Lernmark Å; Better Diabetes Diagnosis Study Group.

Diabetes. 2012 Oct;61(10):2556-64. Epub 2012 Jul 10.

5.

Zinc transporter type 8 autoantibodies (ZnT8A): prevalence and phenotypic associations in latent autoimmune diabetes patients and patients with adult onset type 1 diabetes.

Andersen MK, Härkönen T, Forsblom C, Groop PH, Knip M, Tuomi T.

Autoimmunity. 2013 Jun;46(4):251-8. doi: 10.3109/08916934.2012.741155. Epub 2013 Jan 10.

PMID:
23194113
6.

The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes.

Wenzlau JM, Juhl K, Yu L, Moua O, Sarkar SA, Gottlieb P, Rewers M, Eisenbarth GS, Jensen J, Davidson HW, Hutton JC.

Proc Natl Acad Sci U S A. 2007 Oct 23;104(43):17040-5. Epub 2007 Oct 17.

7.

Characterization of zinc transporter 8 (ZnT8) antibodies in autoimmune diabetic patients from Argentinian population using monomeric, homodimeric, and heterodimeric ZnT8 antigen variants.

Faccinetti NI, Guerra LL, Penas Steinhardt A, Iacono RF, Frechtel GD, Trifone L, Poskus E, Trabucchi A, Valdez SN.

Eur J Endocrinol. 2016 Feb;174(2):157-65. doi: 10.1530/EJE-15-0681. Epub 2015 Nov 13.

8.

Prevalence of ZnT8 antibody in relation to phenotype and SLC30A8 polymorphism in adult autoimmune diabetes: results from the HUNT study, Norway.

Sørgjerd EP, Skorpen F, Kvaløy K, Midthjell K, Grill V.

Autoimmunity. 2013 Feb;46(1):74-9. doi: 10.3109/08916934.2012.732132. Epub 2012 Nov 8.

PMID:
23061550
9.

Correlations between islet autoantibody specificity and the SLC30A8 genotype with HLA-DQB1 and metabolic control in new onset type 1 diabetes.

Brorsson C, Vaziri-Sani F, Bergholdt R, Eising S, Nilsson A, Svensson J, Lernmark Å, Pociot F; Danish Study Group of Childhood Diabetes.

Autoimmunity. 2011 Mar;44(2):107-14. doi: 10.3109/08916934.2010.509120. Epub 2010 Sep 14.

PMID:
20836749
10.

Changes in Zinc Transporter 8 Autoantibodies Following Type 1 Diabetes Onset: The Type 1 Diabetes Genetics Consortium Autoantibody Workshop.

Wenzlau JM, Frisch LM, Hutton JC, Fain PR, Davidson HW.

Diabetes Care. 2015 Oct;38 Suppl 2:S14-20. doi: 10.2337/dcs15-2004.

11.

Zinc transporter 8 (ZnT8) autoantibody epitope specificity and affinity examined with recombinant ZnT8 variant proteins in specific ZnT8R and ZnT8W autoantibody-positive type 1 diabetes patients.

Skärstrand H, Krupinska E, Haataja TJ, Vaziri-Sani F, Lagerstedt JO, Lernmark Å.

Clin Exp Immunol. 2015 Feb;179(2):220-9. doi: 10.1111/cei.12448.

12.

Genetic association of zinc transporter 8 (ZnT8) autoantibodies in type 1 diabetes cases.

Howson JM, Krause S, Stevens H, Smyth DJ, Wenzlau JM, Bonifacio E, Hutton J, Ziegler AG, Todd JA, Achenbach P.

Diabetologia. 2012 Jul;55(7):1978-84. doi: 10.1007/s00125-012-2540-2. Epub 2012 Apr 12.

13.

Relationship between ZnT8Ab, the SLC30A8 gene and disease progression in children with newly diagnosed type 1 diabetes.

Nielsen LB, Vaziri-Sani F, Pörksen S, Andersen ML, Svensson J, Bergholdt R, Pociot F, Hougaard P, de Beaufort C, Castaño L, Mortensen HB, Lernmark A, Hansen L; Hvidoere Study Group on Childhood Diabetes.

Autoimmunity. 2011 Dec;44(8):616-23. doi: 10.3109/08916934.2011.576724. Epub 2011 May 23.

PMID:
21604969
14.

Kinetics of the post-onset decline in zinc transporter 8 autoantibodies in type 1 diabetic human subjects.

Wenzlau JM, Walter M, Gardner TJ, Frisch LM, Yu L, Eisenbarth GS, Ziegler AG, Davidson HW, Hutton JC.

J Clin Endocrinol Metab. 2010 Oct;95(10):4712-9. doi: 10.1210/jc.2010-0169. Epub 2010 Jul 7.

15.

Zinc transporter 8 autoantibodies in fulminant, acute-onset, and slow-onset patients with type 1 diabetes.

Kawasaki E, Nakamura K, Kuriya G, Satoh T, Kobayashi M, Kuwahara H, Abiru N, Yamasaki H, Matsuura N, Miura J, Uchigata Y, Eguchi K.

Diabetes Metab Res Rev. 2011 Nov;27(8):895-8. doi: 10.1002/dmrr.1269.

PMID:
22069281
16.

Zinc transporter 8 autoantibodies in patients with type 1 diabetes from a multiethnic population and their first degree relatives.

Araujo DB, Skärstrand H, Barone B, Dantas JR, Kupfer R, Zajdenverg L, Milech A, Vaziri-Sani F, Oliveira JE, Rodacki M.

Arq Bras Endocrinol Metabol. 2014 Oct;58(7):737-43.

17.

Triple specificity of ZnT8 autoantibodies in relation to HLA and other islet autoantibodies in childhood and adolescent type 1 diabetes.

Andersson C, Vaziri-Sani F, Delli A, Lindblad B, Carlsson A, Forsander G, Ludvigsson J, Marcus C, Samuelsson U, Ivarsson S, Lernmark A, Larsson HE; BDD Study Group.

Pediatr Diabetes. 2013 Mar;14(2):97-105. doi: 10.1111/j.1399-5448.2012.00916.x. Epub 2012 Sep 10.

PMID:
22957668
18.

Positive autoantibodies to ZnT8 indicate elevated risk for additional autoimmune conditions in patients with Addison's disease.

Fichna M, Rogowicz-Frontczak A, Żurawek M, Fichna P, Gryczyńska M, Zozulińska-Ziółkiewicz D, Ruchała M.

Endocrine. 2016 Jul;53(1):249-57. doi: 10.1007/s12020-016-0916-7. Epub 2016 Mar 14.

19.

Differences in the humoral autoreactivity to zinc transporter 8 between childhood- and adult-onset type 1 diabetes in Japanese patients.

Kawasaki E, Nakamura K, Kuriya G, Satoh T, Kobayashi M, Kuwahara H, Abiru N, Yamasaki H, Matsuura N, Miura J, Uchigata Y, Eguchi K.

Clin Immunol. 2011 Feb;138(2):146-53. doi: 10.1016/j.clim.2010.10.007. Epub 2010 Nov 10.

PMID:
21067978
20.

A novel triple mix radiobinding assay for the three ZnT8 (ZnT8-RWQ) autoantibody variants in children with newly diagnosed diabetes.

Vaziri-Sani F, Delli AJ, Elding-Larsson H, Lindblad B, Carlsson A, Forsander G, Ivarsson SA, Ludvigsson J, Marcus C, Lernmark Å.

J Immunol Methods. 2011 Aug 31;371(1-2):25-37. doi: 10.1016/j.jim.2011.06.011. Epub 2011 Jun 25.

Supplemental Content

Support Center